SMA High-Throughput Phenotypic Screening Assay Service
Spinal muscular atrophy (SMA) is a neurodegenerative disease caused by SMN1 gene mutations. Drive your SMA drug discovery forward. Our in vitro high-throughput phenotypic screening service combines cutting-edge technology with tailored solutions to expedite the development of targeted therapies. From assay design to data analysis, we provide comprehensive support for your research. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
Patient-Specific iPSC-Derived Motor Neuron Models
We leverage patient-specific induced pluripotent stem cells (iPSCs) to generate motor neurons that faithfully recapitulate the pathological hallmarks of SMA. This robust in vitro model allows for comprehensive assessment of compound efficacy and safety, including quantification of SMN protein levels, evaluation of neuronal survival rates, and functional characterization through axon growth analysis and electrophysiological recordings.
Fig.1 SMA patient iPSC-derived motor neuron.1
High-Throughput Phenotypic Screening Assays
Leveraging cutting-edge technology, Creative Biolabs delivers robust high-throughput phenotypic screening services for SMA research. Our platform encompasses fluorescence, luminescence, and colorimetric detection, supporting both array- and pool-based screening (FACS, NGS). Integrated cell immunophenotyping provides in-depth cellular analysis, enabling a multifaceted approach to discovery.
Accelerate SMA Drug Discovery with Our Advanced High Content Screening Platform. Our automated imaging and AI-powered analysis system enables simultaneous detection of multi-parametric phenotypes, including nuclear morphology, cell apoptosis, and SMN expression. Screen thousands of compounds in a single experiment and dramatically enhance your drug discovery efficiency.
- Joint Biomarker Validation
We combine candidate biomarkers, such as neurofilament protein (NF), with SMN2 splicing regulation analysis. This multidimensional approach provides robust efficacy evaluation and facilitates seamless preclinical data translation.
- Accurate Quantification of SMN Copy Number
Precise SMN Copy Number Determination for SMA Research. Utilizing qPCR and melting curve technology, we deliver highly sensitive detection of SMN1/SMN2 gene copy number variations. This accurate quantification provides a critical foundation for sample stratification and optimized program design.
Applications
Efficient Drug Discovery: Streamline your drug screening process to quickly pinpoint small molecules, siRNA, and gene therapy candidates that boost SMN protein production and neuronal health.
Comprehensive Mechanistic Studies: Delve into the intricacies of SMN2 splicing regulation, explore neuroprotective pathways, and validate potential drug targets.
Translational Preclinical Validation: Bridge the gap between in vitro findings and clinical success by predicting patient responses and refining clinical trial strategies.
We combine cutting-edge disease models, comprehensive multi-omics analysis, and automated high-throughput platforms to dramatically accelerate your research. Injecting robust scientific power into the fight against SMA, our services are designed to streamline your drug discovery process.
Ready to customize a screening plan tailored to your specific needs? Contact our expert team today and let us help you pave the way for groundbreaking SMA therapies.
Reference
- Fuller, Heidi R., et al. "Spinal muscular atrophy patient iPSC-derived motor neurons have reduced expression of proteins important in neuronal development." Frontiers in cellular neuroscience 9 (2016): 506. Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-GD2 Antibody (NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Rat Muller Cell (Cat#: NCL2110P040)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)